Micro GLP-1 vs prescription GLP-1
Prescription GLP-1 medications are synthetic drugs that act on the GLP-1 receptor. Micro GLP-1 is a plant extract that raises the GLP-1 your body already makes. Different mechanism, different scale, different rules.
Two different things
They share three letters and a number, and almost nothing else. Prescription GLP-1 medications are synthetic drugs that act on the GLP-1 receptor directly. Micro GLP-1 is a plant extract that raises the GLP-1 your body already makes. The mechanism is different, the scale is different, and the rules around each are different. This page sets them side by side so nobody confuses one for the other.
| Prescription GLP-1 | Micro GLP-1 | |
|---|---|---|
| What it is | A synthetic peptide (semaglutide, tirzepatide, liraglutide and others) | CQR-300, a standardized extract of Cissus quadrangularis |
| How it works | Binds the GLP-1 receptor directly and resists breakdown for days | Raises the body's own active GLP-1 and lowers DPP-4, the enzyme that clears it |
| Effect size | Large. Pharmacological. | Modest. Physiological. |
| Form | Weekly or daily injection; one oral tablet | A powder stick in a daily energy drink |
| Access | Prescription only, with medical supervision | Over the counter |
| Regulated as | A drug, approved for specific conditions | A food |
| Studied for | Type 2 diabetes, chronic weight management, cardiovascular outcomes | Body fat, active GLP-1, energy intake |
How prescription GLP-1 works
Semaglutide and its relatives are built to look like GLP-1 to the receptor while resisting the enzyme that clears the natural hormone. One dose stays active for about a week. The receptor is stimulated continuously, at levels the body never produces on its own. The results are correspondingly large: in the main semaglutide trial, body weight fell about 15% on average over 68 weeks. Side effects, mostly nausea and other gastrointestinal effects, are common, which is one reason these medications are prescribed and titrated by a clinician. They are approved for type 2 diabetes and for chronic weight management in people who meet specific criteria.
How Micro GLP-1 works
CQR-300 does not touch the receptor. It changes how much of your own GLP-1 is in circulation. In a 16-week randomized, placebo-controlled trial of 248 adults at 300 mg a day, active GLP-1 rose 321%, from 13.13 to 55.33 pg/mL, while DPP-4 activity fell 17.8%. Participants ate 17.5% fewer calories a day and body fat fell 10.9%, all versus placebo.¹ The full study is on the CQR-300 page.
Scale
A 321% rise sounds enormous until you place it. 55 pg/mL of active GLP-1 is a strong natural level, the kind of signal a good meal produces. A prescription medication produces receptor activation that no meal and no extract approaches. Micro GLP-1 is not a weaker version of the drug. It is a different lever, the body's own, pulled a little harder.
Who each is for
Prescription GLP-1 is a medical treatment for people who meet the criteria, decided with a prescriber. Micro GLP-1 is a daily habit for people holding a calorie deficit without medication who want their energy drink to help with appetite. It makes no claim to treat anything, and the Micro GLP-1 page is careful to say so.
Taking both
Ask your prescriber. Micro GLP-1 is not a drug, but anything that touches appetite and metabolism belongs in that conversation, and your prescriber is the person to have it with. The same applies if you are stepping down or coming off a medication: that is a plan to make with them, not with a label.
In one sentence
Prescription GLP-1 replaces the signal with a stronger synthetic one. Micro GLP-1 turns up the signal you already have.
¹ Medicina 62(1):41, 2026. Randomized, placebo-controlled, 16 weeks, 248 adults, 300 mg CQR-300 per day. A study of the ingredient, not of Calla. Semaglutide figure: STEP 1 trial, New England Journal of Medicine, 2021. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.